Business and Finance3 months ago
Kura Oncology Secures $30 Million Milestone Payment in Ziftomenib AML Program with Kyowa Kirin
Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on precision cancer treatments, has received a $30 million development milestone payment from its collaboration partner...
